Time to maximum effect of lansoprazole on gastric pH in normal male volunteers

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 6, 1996, Pages 897-904

  Bell, N J V ^a   Hunt, R H ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE;

ADULT; AREA UNDER THE CURVE; ARTICLE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SAFETY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH PH;

EID: 0029804467     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.103242000.x     Document Type: Article

References (26)

1. +-ATPase inhibitor, on gastric pH and serum gastrin. Aliment Pharmacol Ther 1992; 6: 359-72.
2. Prichard PJ Yeomans ND, MLhaly GW, et al. Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage. Gastroenterology 1985; 88: 64-98.
3. Tolman KG, Sanders SW, Buchi KN. Gastric pH levels after 15 mg and 30 mg of lansoprazole and 20 mg omeprazole. Gastroenterology 1994; 106 (4): A197 (Abstract).
4. Müller P, Dammann HG, Leucht U, Simon B. Human gastric-acid secretion following repeated doses of AG-1749. Aliment Pharmacol Ther 1989: 3: 193-8.
5. +)-ATPase in vivo by omeprazole. Biochem Biophys Res Commun 1985; 126: 78-82.
6. Nagaya H, Satoh H, Maki Y. Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells. J Pharmacol Exp Ther 1990: 252: 1289-95.
7. Olbe L, Cederberg C, Lind T, Olausson M. Effect of omeprazole on gastric acid secretion and plasma gastrin in man. Scand J Gastroenterol 1989; 24 (Suppl. 166): 27-32.
8. Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L. Effect of omeprazole-a gastric proton pump inhibitor - on pentagastrin stimulated acid secretion in man. Gut 1983: 24: 270-6.
9. Howden CW, Meredith PA, Forrest JAH, Reid JL. Oral pharmacokinetics of omeprazole. J Clin Pharmacol 1984; 26: 641-3.
10. Delhotal-Landes B, Flouvat B, Duchier P. et al. Pharmaco-kinetics of lansoprazole in patients with renal or liver disease of varying severity. Eur J Clin Pharmacol 1993; 45: 367-71.
11. Anderson T, Andren K, Cederberg C, et al. Pharmacokinetics and bioavailability of omeprazole after single and-repeated oral administration in healthy subjects. Br J Clin Pharmacol 1990: 29: 557-63.
12. Burget DW, Chiverton SG, Hunt RH. Is there an optimal degree of acid suppression in healing duodenal ulcer? A model of the relationship between ulcer healing and acid suppression. Gastroenterology 1990; 99: 345-51.
13. Howden CW, Burget DW, Hunt RH. A meta-analysis to predict gastric ulcer healing from acid suppression. Gastroenterology 1991 ; 100: A85.
14. Bell NJV, Burget DW, Howden CW, Wilkinson J, Hunt RH. Appropriate acid suppression for the management of gastroesophageal reflux disease. Digestion 1992; 51 (Suppl. 1): 59-67.
15. Londong W, Barth H, Dammann HG, Hengels KJ, et al. Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole. Aliment Pharmacol Ther 1991 ; 5: 245-54.
16. Hotz J, Kleinert R, Grymbowsky T, Hennig U, Schwarz JA. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration. Aliment Pharmacol Ther 1992: 6: 87-95.
17. Licht H, Andrieu J, Bognel JC, et al. Lansoprazole versus ranitidine in the treatment of duodenal ulcers: Results of a controlled, randomized, double-blind test on parallel groups. Med Chir Dig 1990; 19: 251-5.
18. Aaronson R, Dorsch E, Padgett C, Jennings D, Greski P. Lansoprazole heals duodenal ulcer. Am J Gastroenterology 1991; 86: 1307 (Abstract).
19. Ekstrom P, Unge P, Carling L, et al. Lansoprazole vs. omeprazole in active duodenal ulcer - a healing study. Gastroenterology 1993; 104: A74.
20. Louw JA, van Rensburg C, Simjee AE, et al. Lansoprazole versus omeprazole in duodenal ulcer healing. S Afr Med J 1993 ; 83: 777. (Abstract.)
21. Petite JP, Grimaud JC, Rautureau J, Lemaire M. Lansoprazole versus omeprazole in the treatment of active duodenal ulcer. Gastroenterol Clin Biol 1991; 15; A111.
22. Wormsley KG, Bardhan KD, Morgan AG, et al. Lansoprazole (Lan) is more effective than ranitidine (Ran) in the healing of gastric ulcer (GU). Gut 1992; 33 (Suppl. 1): Tl90.
23. Movva R, Sahba B, Jennings D, Levy C, Greski-Rose P & the Lansoprazole Study Group. Lansoprazole heals gastric ulcers. Gastroenterology 1992: 102: A129.
24. Hatlebakk JG, Berstad A, Carling L, et al. Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trial. Scand J Gastroenterol 1993; 28: 224-8.
25. Hunt RH. The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1995: 9 (Suppl. 1): 3-7.
26. Colin-Jones DG. Safety of lansoprazole. Aliment Pharmacol Ther 1993: 7 (Suppl. 1): 56-60.